Global Over The Counter (OTC) Drugs Sales Market Report 2021

1 Over The Counter (OTC) Drugs Market Overview

• 1.1 Over The Counter (OTC) Drugs Product Scope
• 1.2 Over The Counter (OTC) Drugs Segment by Type
  • 1.2.1 Global Over The Counter (OTC) Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Analgesics
  • 1.2.3 Dermatology Products
  • 1.2.4 Gastrointestinal Products
  • 1.2.5 Vitamins, Mineral, and Supplements (VMS)
  • 1.2.6 Weight Loss/Dietary Products
  • 1.2.7 Ophthalmic Products
  • 1.2.8 Sleeping Aids
  • 1.2.9 Others
• 1.3 Over The Counter (OTC) Drugs Segment by Application
  • 1.3.1 Global Over The Counter (OTC) Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacy
  • 1.3.5 Others
• 1.4 Over The Counter (OTC) Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Over The Counter (OTC) Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Over The Counter (OTC) Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Over The Counter (OTC) Drugs Price Trends (2016-2027)

2 Over The Counter (OTC) Drugs Estimates and Forecasts by Region

• 2.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Over The Counter (OTC) Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Over The Counter (OTC) Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global Over The Counter (OTC) Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Over The Counter (OTC) Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Over The Counter (OTC) Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe Over The Counter (OTC) Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China Over The Counter (OTC) Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan Over The Counter (OTC) Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Over The Counter (OTC) Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India Over The Counter (OTC) Drugs Estimates and Projections (2016-2027)

3 Global Over The Counter (OTC) Drugs Competition Landscape by Players

• 3.1 Global Top Over The Counter (OTC) Drugs Players by Sales (2016-2021)
• 3.2 Global Top Over The Counter (OTC) Drugs Players by Revenue (2016-2021)
• 3.3 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2020)
• 3.4 Global Over The Counter (OTC) Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers Over The Counter (OTC) Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Over The Counter (OTC) Drugs Market Size by Type

• 4.1 Global Over The Counter (OTC) Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Over The Counter (OTC) Drugs Price by Type (2016-2021)
• 4.2 Global Over The Counter (OTC) Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Type (2022-2027)

5 Global Over The Counter (OTC) Drugs Market Size by Application

• 5.1 Global Over The Counter (OTC) Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Over The Counter (OTC) Drugs Price by Application (2016-2021)
• 5.2 Global Over The Counter (OTC) Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Application (2022-2027)

6 North America Over The Counter (OTC) Drugs Market Facts & Figures

• 6.1 North America Over The Counter (OTC) Drugs Sales by Company
  • 6.1.1 North America Over The Counter (OTC) Drugs Sales by Company (2016-2021)
  • 6.1.2 North America Over The Counter (OTC) Drugs Revenue by Company (2016-2021)
• 6.2 North America Over The Counter (OTC) Drugs Sales Breakdown by Type
  • 6.2.1 North America Over The Counter (OTC) Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Over The Counter (OTC) Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America Over The Counter (OTC) Drugs Sales Breakdown by Application
  • 6.3.1 North America Over The Counter (OTC) Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Over The Counter (OTC) Drugs Sales Breakdown by Application (2022-2027)

7 Europe Over The Counter (OTC) Drugs Market Facts & Figures

• 7.1 Europe Over The Counter (OTC) Drugs Sales by Company
  • 7.1.1 Europe Over The Counter (OTC) Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe Over The Counter (OTC) Drugs Revenue by Company (2016-2021)
• 7.2 Europe Over The Counter (OTC) Drugs Sales Breakdown by Type
  • 7.2.1 Europe Over The Counter (OTC) Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Over The Counter (OTC) Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe Over The Counter (OTC) Drugs Sales Breakdown by Application
  • 7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Over The Counter (OTC) Drugs Market Facts & Figures

• 8.1 China Over The Counter (OTC) Drugs Sales by Company
  • 8.1.1 China Over The Counter (OTC) Drugs Sales by Company (2016-2021)
  • 8.1.2 China Over The Counter (OTC) Drugs Revenue by Company (2016-2021)
• 8.2 China Over The Counter (OTC) Drugs Sales Breakdown by Type
  • 8.2.1 China Over The Counter (OTC) Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Over The Counter (OTC) Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China Over The Counter (OTC) Drugs Sales Breakdown by Application
  • 8.3.1 China 245 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Over The Counter (OTC) Drugs Market Facts & Figures

• 9.1 Japan Over The Counter (OTC) Drugs Sales by Company
  • 9.1.1 Japan Over The Counter (OTC) Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan Over The Counter (OTC) Drugs Revenue by Company (2016-2021)
• 9.2 Japan Over The Counter (OTC) Drugs Sales Breakdown by Type
  • 9.2.1 Japan Over The Counter (OTC) Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Over The Counter (OTC) Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan Over The Counter (OTC) Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Over The Counter (OTC) Drugs Market Facts & Figures

• 10.1 Southeast Asia Over The Counter (OTC) Drugs Sales by Company
  • 10.1.1 Southeast Asia Over The Counter (OTC) Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Over The Counter (OTC) Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia Over The Counter (OTC) Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia Over The Counter (OTC) Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Over The Counter (OTC) Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Over The Counter (OTC) Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Over The Counter (OTC) Drugs Market Facts & Figures

• 11.1 India Over The Counter (OTC) Drugs Sales by Company
  • 11.1.1 India Over The Counter (OTC) Drugs Sales by Company (2016-2021)
  • 11.1.2 India Over The Counter (OTC) Drugs Revenue by Company (2016-2021)
• 11.2 India Over The Counter (OTC) Drugs Sales Breakdown by Type
  • 11.2.1 India Over The Counter (OTC) Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Over The Counter (OTC) Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India Over The Counter (OTC) Drugs Sales Breakdown by Application
  • 11.3.1 India Over The Counter (OTC) Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Over The Counter (OTC) Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Over The Counter (OTC) Drugs Business

• 12.1 Bayer AG
  • 12.1.1 Bayer AG Corporation Information
  • 12.1.2 Bayer AG Business Overview
  • 12.1.3 Bayer AG Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
  • 12.1.5 Bayer AG Recent Development
• 12.2 Boehringer Ingelheim
  • 12.2.1 Boehringer Ingelheim Corporation Information
  • 12.2.2 Boehringer Ingelheim Business Overview
  • 12.2.3 Boehringer Ingelheim Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Products Offered
  • 12.2.5 Boehringer Ingelheim Recent Development
• 12.3 GlaxoSmithKline PLC
  • 12.3.1 GlaxoSmithKline PLC Corporation Information
  • 12.3.2 GlaxoSmithKline PLC Business Overview
  • 12.3.3 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Products Offered
  • 12.3.5 GlaxoSmithKline PLC Recent Development
• 12.4 Johnson & Johnson
  • 12.4.1 Johnson & Johnson Corporation Information
  • 12.4.2 Johnson & Johnson Business Overview
  • 12.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Products Offered
  • 12.4.5 Johnson & Johnson Recent Development
• 12.5 Novartis International AG
  • 12.5.1 Novartis International AG Corporation Information
  • 12.5.2 Novartis International AG Business Overview
  • 12.5.3 Novartis International AG Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Novartis International AG Over The Counter (OTC) Drugs Products Offered
  • 12.5.5 Novartis International AG Recent Development
• 12.6 Pfizer,Inc.
  • 12.6.1 Pfizer,Inc. Corporation Information
  • 12.6.2 Pfizer,Inc. Business Overview
  • 12.6.3 Pfizer,Inc. Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Products Offered
  • 12.6.5 Pfizer,Inc. Recent Development
• 12.7 PGT healthcare
  • 12.7.1 PGT healthcare Corporation Information
  • 12.7.2 PGT healthcare Business Overview
  • 12.7.3 PGT healthcare Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 PGT healthcare Over The Counter (OTC) Drugs Products Offered
  • 12.7.5 PGT healthcare Recent Development
• 12.8 Sanofi S.A
  • 12.8.1 Sanofi S.A Corporation Information
  • 12.8.2 Sanofi S.A Business Overview
  • 12.8.3 Sanofi S.A Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Sanofi S.A Over The Counter (OTC) Drugs Products Offered
  • 12.8.5 Sanofi S.A Recent Development
• 12.9 Takeda
  • 12.9.1 Takeda Corporation Information
  • 12.9.2 Takeda Business Overview
  • 12.9.3 Takeda Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Takeda Over The Counter (OTC) Drugs Products Offered
  • 12.9.5 Takeda Recent Development

13 Over The Counter (OTC) Drugs Manufacturing Cost Analysis

• 13.1 Over The Counter (OTC) Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Over The Counter (OTC) Drugs
• 13.4 Over The Counter (OTC) Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Over The Counter (OTC) Drugs Distributors List
• 14.3 Over The Counter (OTC) Drugs Customers

15 Market Dynamics

• 15.1 Over The Counter (OTC) Drugs Market Trends
• 15.2 Over The Counter (OTC) Drugs Drivers
• 15.3 Over The Counter (OTC) Drugs Market Challenges
• 15.4 Over The Counter (OTC) Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List